Narrow search
Showing 1 - 10 of 14,102
Cover Image
Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany
Herr, Annika; Suppliet, Moritz - Düsseldorf Institute for Competition Economics (DICE), … - 2012
Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to …
Persistent link: https://www.econbiz.de/10010956760
Cover Image
Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles
Sauer, Corinne; Sauer, Robert - Jerusalem Institute for Market Studies (JIMS) - 2005
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process. Lack of competition in the drug approval process has led to exceedingly high drug development costs....
Persistent link: https://www.econbiz.de/10004995401
Cover Image
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure
Magazzini, Laura; Pammolli, Fabio; Riccaboni, Massimo - Volkswirtschaftliche Fakultät, … - 2004
distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …
Persistent link: https://www.econbiz.de/10005034975
Cover Image
Deregulating the Norwegian Pharmaceuticals Market - Consequences for Costs and Availability
Rudholm, Niklas - Handelns Utredningsinstitut (HUI Research) - 2007
The aim of this paper is to analyze the impact of the deregulation of the Norwegian pharmaceuticals market in 2001 on … pharmacies have not decreased as a consequence of the deregulation of the Norwegian pharmaceuticals market. The deregulation of …
Persistent link: https://www.econbiz.de/10005419304
Cover Image
Business concentration through the eyes of the HHI
Djolov, George - In: International Journal of Business and Economic Sciences … 7 (2014) 2, pp. 105-127
This paper examines the understanding of business concentration through the Her findahl-Hirschman Index (HHI), by showing that this index is conceptually a model according to which this concentration is the consequence of a renewal process. This process is prompted by firms engaging in different...
Persistent link: https://www.econbiz.de/10011200077
Cover Image
Hospital Market Structure and Cost Performance: A Case Study
Santerre, Rexford E.; Bennett, Dana C. - In: Eastern Economic Journal 18 (1992) 2, pp. 209-219
Prior research on the nonprice theory of hospital competition uses data prior to the mid-1980s when third party payers were insensitive to hospital prices. Moreover, existing studies fail to test this theory for the different types of hospital ownership. In response to these issues, this...
Persistent link: https://www.econbiz.de/10005641644
Cover Image
Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?
de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - In: Journal of Health Economics 32 (2013) 1, pp. 268-285
We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality …. We show that advertising intensities are strategic substitutes, with the better quality drugs being the ones that are … loyalty is endogenously determined by promotional effort. The model's main results on advertising and pricing strategies are …
Persistent link: https://www.econbiz.de/10010608419
Cover Image
Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?
de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - C.E.P.R. Discussion Papers - 2010
We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality …/side e¤ects. Advertising results in the endogenous formation of two consumer groups: brand loyal and non-brand loyal ones. We … show that advertising strategies are strategic substitutes, with the better quality drugs being the ones that are most …
Persistent link: https://www.econbiz.de/10008680762
Cover Image
Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data
Garavaglia, Christian; Malerba, Franco; Orsenigo, Luigi; … - In: Journal of Economics and Statistics (Jahrbuecher fuer … 234 (2014) 2-3, pp. 274-298
The contribution of this paper is twofold. First, it presents the results of a “history-friendly” simulation model of evolution of the pharmaceutical industry. Second, it aims at contributing to a more general methodological discussion about agent-based models by proposing an econometric...
Persistent link: https://www.econbiz.de/10010907946
Cover Image
Direct-to-Consumer Advertising in Pharmaceutical Markets
Brekke, Kurt R; Kuhn, Michael - Department of Economics and Related Studies, University …
We study effects of direct-to-consumer advertising (DTCA) in a mar- ket with two pharmaceutical firms providing …
Persistent link: https://www.econbiz.de/10005695847